Clinical Trial Update: The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the pharmacology and hemodynamics of dexmedetomidine in children with congenital heart disease, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect
• Congenital Heart Disease
• Patent Ductus Arteriosus

Drugs mentioned

• PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: Children's National Research Institute | Conditions: Cardiac Transplant, Patent Ductus Arterious | Phase 3 | Status: COMPLETED | Results posted: 2015-06-26